| Literature DB >> 33195553 |
Liang Deng1, Yuwei Han1, Chi Tang1, Qingchao Liao1, Zheng Li1.
Abstract
Early pregnancy in jennies is routinely determined by palpation per rectum or ultrasonography and also by detecting steroid hormone and chorionic gonadotropin levels in the blood, plasma, and serum. Herein we applied label-free mass spectrometry-based quantitative proteomics to identify serum proteins that were differentially expressed between early pregnant (day 45 after ovulation) and non-pregnant jennies. Bioinformatics analysis allowed illustration of pathways potentially involved in early pregnancy. We identified 295 proteins from a total of 2,569 peptides. Twenty-five proteins (22 upregulated and three downregulated) were significantly differentially expressed between the early pregnant and non-pregnant groups. The majority of the differentially expressed proteins were involved in defense response, early embryonic development, and hormone signaling pathways. Furthermore, functional protein analyses suggested that proteins were involved in binding, enzyme inhibitor activity, and enzyme regulator activity. Five serum proteins-granulin precursor/acrogranin, transgelin-2, fibronectin, fibrinogen-like 1, and thrombospondin 1-can be considered as novel, reliable candidates to detect pregnancy in jennies. To the best of our knowledge, this is the first study to use label-free mass spectrometry-based quantitative proteomics to analyze serum proteins during early pregnancy in jennies. Our results should facilitate the identification of valuable pregnancy diagnostic markers in early pregnant jennies.Entities:
Keywords: biomarkers; early pregnancy; jennies; proteomics; serum proteins
Year: 2020 PMID: 33195553 PMCID: PMC7642908 DOI: 10.3389/fvets.2020.569587
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Unique peptides for the identified proteins.
Differentially expressed proteins in the serum of early pregnant (P group) and non-pregnant (NP group) jennies.
| F6YR34 | Thrombospondin 1 | THBS1 | 21.1 | 129.56 | 14.43 | 0.0432 | ↑ |
| F7CN05 | Fibronectin | FN1 | 39.7 | 252.55 | 3.32 | 0.0045 | ↑ |
| F6RMK1 | C-X-C motif chemokine | LOC100630489 | 31.5 | 11.835 | 2.92 | 0.0122 | ↑ |
| F6ZRF6 | Serpin family A member 7 | SERPINA7 | 18.6 | 46.64 | 2.25 | 0.0346 | ↑ |
| A0A0A1E971 | Immunoglobulin lambda light chain variable region (Fragment) | IGL | 30.4 | 23.267 | 1.91 | 0.0363 | ↑ |
| F7ATS5 | Golgi membrane protein 1 | GOLM1 | 12.5 | 41.218 | 1.87 | 0.0276 | ↑ |
| Q5IF07 | Insulin-like growth factor binding protein-2 (Fragment) | IGFBP-2 | 17.7 | 16.042 | 1.82 | 0.0014 | ↑ |
| F6WA57 | Lymphocyte cytosolic protein 1 | LCP1 | 35.8 | 70.347 | 1.74 | 0.0409 | ↑ |
| F6Y950 | Chromosome 2 C4orf33 homolog | C2H4orf33 | 6.5 | 23.394 | 1.64 | 0.0486 | ↑ |
| F6Y2H3 | Peptidase D | PEPD | 12.2 | 54.827 | 1.53 | 0.0061 | ↑ |
| A0A0A1E3W4 | Immunoglobulin lambda light chain variable region (Fragment) | IGL | 25.4 | 23.511 | P | ↑ | |
| F6VP61 | Serpin family B member 10 | SERPINB10 | 5.8 | 45.412 | P | ↑ | |
| F6QXN5 | Transgelin2 | TAGLN2 | 9.3 | 23 | P | ↑ | |
| F6RCZ8 | Triggering receptor expressed on myeloid cells like 1 | TREML1 | 5 | 33.597 | P | ↑ | |
| F6RLT8 | Calpain small subunit 1 | CAPNS1 | 4.9 | 28.099 | P | ↑ | |
| F6RMQ1 | GLI pathogenesis related 2 | GLIPR2 | 17.2 | 16.905 | P | ↑ | |
| F6T962 | EGF containing fibulin extracellular matrix protein 2 | EFEMP2 | 6.5 | 49.439 | P | ↑ | |
| F6ZEJ2 | HGF activator | HGFAC | 7.2 | 55.76 | P | ↑ | |
| F7AB03 | Granulin precursor | GRN | 6.6 | 63.195 | P | ↑ | |
| F7DIN1 | Fibrinogen like 1 | FGL1 | 4.4 | 36.475 | P | ↑ | |
| F7E2K1 | Uncharacterized protein | N/A | 2.1 | 72.262 | P | ↑ | |
| P19794 | Lutropin/choriogonadotropin subunit beta | LHB | 10.1 | 17.943 | P | ↑ | |
| F7BSN5 | Uncharacterized protein | N/A | 7.6 | 59.264 | 0.51 | 0.0190 | ↓ |
| F7DU87 | Uncharacterized protein | BPIFA2 | 39.8 | 26.915 | 0.28 | 0.0012 | ↓ |
| F7ATL5 | Keratin 14 | KRT14 | 8.2 | 41.036 | NP | ↓ |
FC, fold change, mean value of peak area obtained from the P group/mean value of peak area obtained from the NP group. If the fold-change value was >1.5, the relative content of serum proteins in the P group was higher that than in the NP group, and if the fold-change value was <0.67, the relative content of serum proteins in the P group was less than that in the NP group.
coverage (%) = percentage of the protein sequence covered by identified peptides.
uniquely expressed serum proteins in the P group.
uniquely expressed serum proteins in the NP group.
“↑” = upregulated serum proteins; “↓” = downregulated serum proteins.
Figure 2A volcano plot of common proteins identified in the serum of early pregnant and non-pregnant jennies. This plot was drawn on the basis of the fold change and P-value between the P and NP groups. Red and green dots represent upregulated and downregulated common proteins, respectively (fold change ≥1.5 and P < 0.05). Gray dots represent proteins without any difference.
Figure 3GO enrichment analyses of DEPs identified in the serum of early pregnant and non-pregnant jennies. Most proteins could be divided into three major categories: biological process, cellular component, and molecular function.
Figure 4KEGG pathway enrichment analysis of DEPs identified in the serum of early pregnant and non-pregnant jennies.
Figure 5Protein–protein interaction network analysis based on DEPs in the P group vs. the NP group.